Rheonix Completes $12.6M Series A financing

Rheonix, Inc., an Ithaca, NY-based developer of a polymer chip microfluidic technology for the molecular diagnostics industry, completed a $12.6m Series A financing
The funding was provided by a syndicate of regional and international firms, which was led by the Cayuga Venture Fund and Bill and Eric Allyn.
The new capital will enable the company to continue development of its Rheonix CARD™ (Chemistry And Reagent Device) system, an analytic platform for the life-science industry which vertically integrates all the functions of traditional molecular diagnostic instrumentation into a single system to achieve raw sample preparation, molecular amplification and multiplex analysis.
The Rheonix CARD system provides a modular solution for rapid product development, allowing end users to automate new or existing assays using single or multiple raw clinical samples.

Join the discussion